Targeting GRK2 in the Heart
$58,003R01FY2022HLNIH
Duke University, Durham NC
Investigators
Linked publications & trials
Paper 39208127Paper 37013982Paper 36884028Paper 35878706Paper 33548241Paper 33513081Paper 33377274Paper 32640834Paper 32216616Paper 32096362Paper 30946029Paper 30920389Paper 30538174Paper 30175279Paper 30147654Paper 29917053Paper 29802197Paper 29535114Paper 26796036Paper 26300236Paper 26005840Paper 25918050Paper 25576627Paper 24492610Paper 24486513Paper 24305416Paper 24218435Paper 23989716Paper 23376831Paper 23273595Paper 23224879Paper 22261894Paper 22179058Paper 22081699Paper 21866097Paper 21851887Paper 21775667Paper 21747049Paper 21449665Paper 21362533Paper 21232674Paper 21193587Paper 21139071Paper 21106943Paper 20800067Paper 20718822Paper 20443948Paper 20443814Paper 20351116Paper 20008271Paper 19525383Paper 19103992Paper 18711143Paper 18635825Paper 18566312Paper 18316484Paper 18223549Paper 17827263Paper 17602988Paper 17482545Paper 17322894Paper 17088462Paper 16952982Paper 16762799Paper 16055494Paper 15967848Paper 15524162Paper 15451518Paper 15031261Paper 12865503Paper 12777394Paper 12679207Paper 12479236Paper 12411459Paper 12054854Paper 11901213Paper 11772881Paper 11499749Paper 11447073Paper 11331748Paper 11306600Paper 11245652Paper 11179056Paper 11123229Paper 11094043Paper 10966835Paper 10671499Paper 10625304
View original record on NIH RePORTER →